Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 11
  • Journal CiteScore: 0.91
  • Journal Impact Factor: 0.6
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Herbal drugs enhance radio toxicity of breast cancer lines with relevance to improving cancer radiotherapy

EuroSciCon Conference on Oncology and Cancer Stem Cell
November 05-06 , 2018 Paris , France

K P Mishra

Former Head of Radiation Biology and Health Sciences Division, Bhabha Atomic Research Center, Mumbai 400 085 India, Present: President, Foundation for Education and Research, Mumbai, India

Posters & Accepted Abstracts: Arch Cancer Res


Increasing incidences and mortalities of cancer have been common in the industrialized world. Breast cancer in women is one of the major diseases in both developed and developing countries. Apart from surgery and chemotherapy, radiotherapy is a most predominant treatment modality but frequently observed problems of general toxicity, exorbitant cost and non-specific action pose profound limitations in the treatment of cancer patients. While considerable technical improvement has been made in delivering the radiation to the target tissue but treatment limitations yet pose many daunting challenges. The search for new drugs for cancer treatment has been a challenging task for biomedical and pharmaceutical companies. A major predicament is faced in the cancer clinic because anticancer drugs as well as radiation kill equally both cancer and normal cells of the patients producing undesirable side effects compelling discontinuation of the treatment. Research is, therefore, warranted to develop non-toxic and affordable drugs for effective treatment of cancer patients. To meet these objectives, our laboratory has been actively attempting to develop novel drugs from plant kingdom and targeted approaches to selectively kill the cancer cells while sparing the normal cells. The results of our studies on MCF-7 and T40D breast cancer lines have shown great promise of enhancing radiosensitivity of these cell lines to gamma radiation in vitro. A developing strategy that holds promise in treatment of cancer patients consists in searching for natural compounds which can selectively enhance tumor cell toxicity to radiation but spare normal cells as desired in clinical settings. Recent research results from our screening studies have found some potent phytodrugs from plant kingdom which display unique ability to cause no or minimal toxicity to normal cells but remarkably sensitize tumor cells to ionizing radiation. The mechanism involves the radiation generated reactive oxygen species (ROS) which trigger induction of apoptosis (cellular suicide) in tumor cells because of the high oxidative stress status in these cells. This talk is designed to present a brief highlight of our recent results based on herbal drugs for improving chemo and radiotherapy of cancer patients. A few examples of notable herbals such as triphala, ellagic acid and silibinin will be given for the observed increased tumor cytotoxicity in tumor cells by compounds from plant sources which hold promise of improving cancer radiotherapy.

Biography :


[email protected]